Genmab Announces Submission of Biologics License Application to U.S. FDA for Subcutaneous Formulation of Daratumumab

Ads

You May Also Like

BioSig Technologies Launches New Corporate Website

Minneapolis, MN, June 08, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device ...

VigiLanz Integrates Infectious Disease Content from Sanford Guide

MINNEAPOLIS, MN--(Marketwired - Nov 29, 2017) - VigiLanz, a digital healthcare intelligence firm, announced ...